GCTK
NASD GlucoTrack Inc$1.21 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.21, $0.13 below the day’s high of $1.34
- YTD change
- -97.92%
- vs 20-day SMA
- -49.06%
- vs 200-day SMA
- -93.34%
Price ranges
Price & Performance
+0.35 (+40.70%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $43,920.00
- GCTK is down 98% since the beginning of the year
- GCTK is down 99% over the past 12 months
- GCTK is down 66% over the past 1 month
- 4% of all GCTK investors are betting against GCTK
GCTK reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -81.8%.
- Previous minute
- +$0.02
- Last hour
- +$0.00
- Last 5 days
- -53.10%
- vs 8-day SMA
- -36.48%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.